Milestone reinforces readership in AI-powered breast cancer detection WELLINGTON, New Zealand, Oct. 24, 2024 /PRNewswire/ -- Volpara Health, a Lunit company…
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its…
Long-term strategic collaboration will support The AI Centre for Value-Based Healthcare's mission and enable faster, more effective adoption of clinically…
System targets faster, earlier, easier CBC results and severe infection detection MORRISVILLE, N.C., Oct. 24, 2024 /PRNewswire/ -- Ad Astra Diagnostics (AAD),…
Integrating genomics into clinical workflows and empowering patients and providers with actionable genetic information NEW YORK, Oct. 24, 2024 /PRNewswire/…
The first project under a new multi-year research collaboration, interrogation of the TAILORx breast cancer trial enables discovery for risk…
CHATHAM, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage…
Additional real-world studies show sustained HAE attack rate reduction after initiating ORLADEYO, regardless of C1-INH status, and patient preference for…
Publication shows that OGM can resolve translocation partners involving MYC in multiple myeloma (MM) more effectively than current methodsThe release…
– Combination of ziftomenib and imatinib shows robust and durable antitumor activity in imatinib-sensitive (1L) and imatinib-resistant (2L/3L) GIST models…